APROCITENTAN (is an active metabolite) 
| APROCITENTAN | ATC C02KN01
CARDIOVASCULAR ANTIHYPERTENSIVE PULMONARY ARTERIAL HYPERTENSION (PAH) ENDOTHELIN RECEPTOR ANTAGONIST ET-1 PREVENTS THE BINDING OF ET-1 TO ITS RECEPTORS ETA AND ETB METABOLITE 20 PERCENT AS POTENT AS THE PARENT DRUG IN VITRO | ORAL | Cmax 2.38 MICROMOLAR Tmax 4.5 HOUR VD 20 LITER PPB 99 PERCENT Cl 0.3 LITER / HOUR HT 41 HOUR SOLUBILITY INSOLUBLE IN WATER | ENDOTHELIN RECEPTOR ET-1 | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
MACITENTAN (has an active metabolite) 
| MACITENTAN | ATC C02KX04 ATC C02KX54
CARDIOVASCULAR ANTIHYPERTENSIVE PULMONARY ARTERIAL HYPERTENSION (PAH) ENDOTHELIN RECEPTOR ANTAGONIST ET-1 PREVENTS THE BINDING OF ET-1 TO ITS RECEPTORS ETA AND ETB | ORAL | VD 50 LITER PPB 99 PERCENT Cl 2.1 LITER / HOUR (EQN) HT 16 HOUR SOLUBILITY NOT SOLUBLE IN WATER | ENDOTHELIN RECEPTOR ET-1 PDB 8XVJ (CRYO-EM STRUCTURE OF ETAR BOUND WITH MACITENTAN) LIGAND CODE = A1D5I (link to the list of PDB complexes) Download experimental 3D coordinates of A1D5I with added hydrogens | Endothelin-1 receptor UNIPROT P25101 EDNRA -- Endothelin B receptor UNIPROT P24530 EDNRB more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |